NSE filing, NSE: WINNY. Summary written from the filing by ALFA Finder's alert engine.
Winny Immigration & Education Services Ltd: key numbers
- Share price
- ₹30.30
- Market cap
- ₹6.58 Cr
- Revenue (annual)
- ₹2.25 Cr
- Net profit (annual)
- ₹-6.33 Cr
- P/E (TTM)
- -1.0×Sector 35.3×
- Promoter holding
- 58.51%
- FII holding
- 3.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Winny Immigration & Education Services Ltd
All →Winny Immigration & Education Services Other Announcement
Winny Immigration filed its half-year Reg 32 statement on IPO fund use. It reports a variation approved by shareholders in November 2025, with no deviation.
Winny Immigration & Education Services H1 FY27 Results: Net Loss of ₹1.2 Cr, Loss Narrows
Winny Immigration & Education Services Ltd reported revenue from operations of ₹1.5 Cr (-16.7% YoY) and a net loss of ₹1.2 Cr for H1 FY27.
- Key figure
- Net loss ₹1.2 Cr
Winny Immigration & Education Services Board Meeting Date
Winny Immigration has scheduled a board meeting on November 5, 2026 to consider half-yearly unaudited financial results. Trading window closes from October 1 to November 7, 2026.
Winny Immigration & Education Services Annual General Meeting
Shareholders of Winny Immigration & Education Services approved a special resolution to vary the utilization of IPO proceeds and extend the time limit for utilization.
Winny Immigration & Education Services Other Announcement
The company has submitted a certificate confirming that the Corporate Governance Report is not applicable to it for the quarter ended 30th September, 2026.
Winny Immigration & Education Services Annual General Meeting
Winny Immigration & Education Services Limited has issued a Postal Ballot notice to seek shareholder approval for varying the utilization of IPO proceeds.
Other product launch announcements
All →Bharat Forge Product Launch
Bharat Forge's defence subsidiary KSSL unveiled the 120mm Rapid Attack Mortar System for Indian Armed Forces and international customers. No order value or contract was announced.
Lupin Product Launch
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
LTM Product Launch
LTM publishes AI-QEM, its Quantum Error Mitigation tool, in IBM's Quantum Functions Catalog, becoming the first global systems integrator to do so.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.